Document Detail


Serum digoxin concentrations in atrial fibrillation: a review.
MedLine Citation:
PMID:  7049644     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Studies evaluating the relationship of serum digoxin concentrations (SDCs) with pharmacodynamic effects in atrial fibrillation have important limitations. In general, a poor correlation is found between SDC and ventricular rate, but this is understandable, considering the many other factors that affect conduction through the atrioventricular node. The ventricular rate, although a clinically important and easily monitored parameter, may not always be a good measure of digoxin effect. In certain patients, signs and symptoms of toxicity may develop before the desired decrease in heart rate. The SDC may provide, in many cases, information that cannot be obtained solely from the clinical response, but is of great relevance to therapeutic decision making.
Authors:
J E Masuhara; R L Lalonde
Related Documents :
901074 - Comparison of the antiarrhythmic activity of quinidine and quinine.
8889364 - Sleep-disordered breathing: a novel predictor of atrial fibrillation after coronary art...
12427594 - Effects of acute reduction of temperature on ventricular fibrillation activation patterns.
2769174 - Primary ventricular fibrillation in acute myocardial infarction.
3369314 - A hyperkinetic heart in uncomplicated active acromegaly. explanation of hypertension in...
8106894 - The use of aspirin in cardiovascular disease.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Drug intelligence & clinical pharmacy     Volume:  16     ISSN:  0012-6578     ISO Abbreviation:  Drug Intell Clin Pharm     Publication Date:    1982 Jul-Aug
Date Detail:
Created Date:  1982-10-21     Completed Date:  1982-10-21     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0212457     Medline TA:  Drug Intell Clin Pharm     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  543-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Atrial Fibrillation / drug therapy*
Digoxin / adverse effects,  blood*,  therapeutic use
Humans
Chemical
Reg. No./Substance:
20830-75-5/Digoxin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A practical guide to interactions involving theophylline kinetics.
Next Document:  Nomifensine maleate (Merital, Hoechst-Roussel).